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a b s t r a c t
Mouse cytochrome P450 2A5 (CYP2A5) is upregulated in various liver diseases and a putative common
feature for all of these conditions is altered cellular redox status. Nuclear factor erythroid 2-like 2 (Nrf2)
is a transcription factor that is post-translationally regulated by oxidative stress and controls the
transcription of protective target genes. In the present study, we have characterized the regulation of
CYP2A5 by Nrf2 and evaluated gene expression, protein content and activity of anti-oxidant enzymes in
the Nrf2þ /þ and Nrf2 / mice model of non-alcoholic fatty liver (NAFLD). After eight weeks of feeding
on a high-fat diet, livers from Nrf2 / mice showed a substantial increase in macro and microvesicular
steatosis and a massive increase in the number of neutrophil polymorphs, compared to livers from wild-
type mice treated similarly. Livers of Nrf2 / mice on the high-fat diet exhibited more oxidative stress
than their wild-type counterparts as assessed by a signiﬁcant depletion of reduced glutathione that was
coupled with increases in malondialdehyde. Furthermore, results in Nrf2-deﬁcient mice showed that
CYP2A5 expression was signiﬁcantly attenuated in the absence of Nrf2, as was found with the
conventional target genes of Nrf2. The treatment of wild-type mice with high-fat diet leaded to nuclear
accumulation of Nrf2, and co-immunoprecipitation experiments showed that Nrf2 was bound to Cyp2a5.
These ﬁndings suggest that the high-fat diet induced alteration in cellular redox status and induction of
CYP2A5 was modulated through the redox-sensitive transcription Nrf2.
Crown Copyright & 2013 Published by Elsevier B.V.
Introduction
Nonalcoholic fatty liver disease (NAFLD) is composed of a
spectrum of pathologies ranging from simple fatty liver (steatosis)
to the more severe nonalcoholic steatohepatitis (NASH). The
proposed mechanism for progression of NAFLD involves a two-
hit theory where lipid accumulation in hepatocytes (the“ﬁrst hit”)
is followed by a “second hit,” including insulin resistance, oxida-
tive stress, and cytokine production [1]. The capacity of a cell to
manage oxidative stress is primarily mediated through antioxidant
response elements or electrophile response elements (AREs), which
are largely under the control of the transcription factor nuclear
factor erythroid 2-like 2 (Nrf2) [2,3]. Nrf2 is primarily a cytosolic
protein due to proteasomal degradation regulated by Keap1 [4].
When a cell is undergoing oxidative stress, Nrf2 escapes Keap1-
mediated degradation, translocates to the nucleus, actives a battery
of redox-homeostasis regulatory genes such as γ-glutamyl cysteine
ligase (γ-GCS), and phase II genes such as glutathione S-transferases
(GST) and NAD(P)H:quinone oxidoreductase1 (NQO1) [5]. Activation
of Nrf2 plays a crucial role in regulating the cytoprotective responses
to a variety of drugs, toxicants, and cellular stresses.
CYP2A5 belongs to the group of P450 enzymes involved in the
metabolism of xenobiotics, such as drugs and environmental tox-
icants [6]. Murine CYP2A5 and its human orthologue CYP2A6 are the
main catalysts of coumarin and nicotine metabolism but have also
been shown to participate in metabolic activation of procarcinogens,
such as aﬂatoxin B1 and nitrosamines [7,8]. A number of studies
have indicated high expression of CYP2A5 in mouse hepatomas and
preneoplastic liver lesions; therefore, CYP2A5 has been suggested to
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be a useful marker for hepatocarcinogenesis [9–12]. Additionally,
CYP2A5 has been found to be up-regulated in several types of
hepatic infections of viral, bacterial, and parasitic origin, which are
associated with an increased risk of hepatocarcinogenesis [13–16].
The mechanistic basis behind these elevated expression levels has
remained enigmatic. A possible explanation for these apparently
unrelated effects on CYP2A5 expression could be involvement of a
common indirect mechanism.
We previously found that mice fed with high-fat diet resulted
in an increase in expression of Nrf2 and CYP2A5 in liver. We
hypothesized that feeding a high-fat diet would cause an elevation
of ROS, which increases Nrf2 levels, and the elevated Nrf2 up-
regulates CYP2A5. To test this hypothesis, we have characterized a
high-fat diet induced model of NAFLD and evaluated gene expres-
sion and protein activity of anti-oxidant enzymes in Nrf2þ /þ and
Nrf2 / mice.
Materials and methods
Chemicals and antibodies
All reagents were obtained from Sigma Chemical Company
(St. Louis, MO, USA) unless otherwise indicated. Rabbit IgG
(sc-2027) and rabbit polyclonal anti-Nrf2 (sc-13032), were from
Santa Cruz Biotechnology Inc. (Santa Cruz, CA). Polyclonal chicken
Cyp2a5 antiserum was a kind gift from Dr. H. Raunio (University of
Kuopio, Kuopio, Finland).
Animal treatment
Six to eight-week-old, ICR male wild-type (Nrf2þ /þ) and Nrf2
knockout mice (Nrf2 /) were purchased from the Animal Experi-
ment Center of General Hospital of Nanjing Military Area Com-
mand [Certiﬁcation no. SCXK (JUN) 2007-012]. They were divided
into four groups of three mice in each group and housed in ﬁlter-
top polycarbonate cages containing wood chip bedding and
maintained in a 12-h light/dark cycle with free access to standard
mouse chow and tap water. After a one-week adaptive period, the
four groups of mice were treated for eight consecutive weeks. The
Nrf2þ /þ and Nrf2 / control groups were fed with the standard
diet. The Nrf2þ /þ and Nrf2 / high-fat model groups were fed
with a high-fat diet (68.5% standard diet, 15% lard, 1% cholesterol,
0.5% bile and 15% dextrin) which induces NAFLD (data not shown).
The mice in all groups were sacriﬁced by CO2 overdose. At the time
of death, blood was collected from the thoracic aorta. The serum
was separated from the cellular elements by centrifugation. The
livers were removed, rinsed in ice-cold saline, and divided for
various assays, as outlined below. All the experimental procedures
were approved by, and conducted in accordance with, the Institu-
tional Animal Use and Care Committee of the Northeast Agricul-
tural University.
Liver histological examination
Fresh liver tissue pieces from four groups of mice were ﬁxed in
10% neutral formalin, embedded in parafﬁn, sliced and stained
with H&E. The slides were examined by a pathologist to detect the
presence of fat, necrosis, ﬁbrosis and inﬂammation. The patholo-
gist scored them from 0 to 4 using the standards proposed by
Dixon for assessing changes in fat and inﬂammation [17]. The sum
of the fat, necrosis, inﬂammation and ﬁbrosis scores was termed
the total histological score. The presence of NAFLD in mice was
diagnosed using standard criteria [18].
Biochemistry analysis
Serum alanine aminotransferase (ALT), aspartate aminotransferase
(AST), alkaline phosphatase (ALP), triglycerides (TG), glucose (GLU),
total protein (TP), high-density lipoprotein (HDL), low-density lipo-
protein (LDL) and total cholesterol (TC) were determined using a
Beckman CX4 automatic biochemical analyzer (Beckman Colter,
Inc., USA).
Measurement of reduced glutathione levels
Liver homogenate was mixed with trichloroacetic acid (TCA)
to a ﬁnal concentration of 5%, and the mixture was incubated at
4 1C for 30 min to extract glutathione (GSH). The TCA extracts
(10 μl) were added to 200 μl of methanol containing 1 mg/ml
o-phthaldehyde and then were incubated for 15 min at 37 1C in
the dark. Fluorescence was measured at 350/420 nm (excitation/
emission). The concentration of GSH was determined from a GSH
standard curve [19].
Lipid peroxidation in livers
Lipid peroxidation in liver was monitored by quantifying
thiobarbituric acid reactive substances (TBARS). About 25 mg of
liver was homogenized in 2 fold volumes of ice-cold PBS, and
TBARS were determined via the OXltek TBARS kit (ZeptoMetrix,
Buffalo, NY). Sample homogenates, as well as malondialdehyde
(MDA) standards, were incubated with sodium dodecyl sulfate
and thiobarbituric acid at 95 1C for 1 h. After incubation, samples
were cooled on ice and centrifuged at 1800g for 15 min. Super-
natants (200 μl) were transferred to a 96-well plate and quantiﬁed
at 532 nm. MDA equivalents were expressed as nmol of MDA
equivalents per gram liver.
Preparation of hepatic microsomes.
Hepatic microsomes were prepared by placing liver aliquots in
0.15 M KCl and homogenized in a polytron homogenizer for 10
strokes. The homogenate was centrifuged at 9000g for 20 min,
and then the resulting supernatant fraction was centrifuged
further at 105,000g for 60 min. The resulting pellets (microsomes)
were re-suspended in 50 mM sodium phosphate buffer (pH 7.4).
All procedures were carried out on ice.
Real-time qPCR
Differences in gene expression levels were quantitated using
Brilliant SYBR Green QPCR Master Mix (Stratagene, La Jolla, CA)
and Mx3005P Q-PCR system (Stratagene). Analyses were done by
the comparative Ct (ΔΔCt) method, wih ﬂuorescence correction by
the passive reference dye ROX and subsequent normalization to
reference gene GAPDH. Sequences for primers used in quantitation
of gene expression are listed in Table 1.
Isolation of nuclear and cytoplasmic proteins from mouse liver
Nuclear and cytoplasmic extracts were prepared with nuclear
and cytoplasmic protein extraction kit according to their protocols
(Beyotime Institute of Biotechnology, Beijing, China). Protein con-
centrations were determined with the BCA Assay Kit from Beyo-
time Biotechnology. Brieﬂy, approximately 0.2 g of mouse liver
was homogenated with 2 ml of ice cold hypotonic buffer A and
buffer B (20:1). The homogenate was incubated at 4 1C for 15 min
and centrifuged at 12,000g for 10 min at 4 1C. The supernatant was
obtained as cytoplasmic extract and the residue was added with
0.2 ml of hypertonic buffer C. The pellet suspension was shaken
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gently for 30 min at 4 1C and then centrifuged at 12,000g 10 min at
4 1C. The supernatant was obtained as nuclei extract. PMSF and
leupeptin were added into buffer A and buffer C before use.
Immunoprecipitation
Liver fractions were extracted as described above. Sufﬁcient
amount of Nrf2 antibody or Cyp2a5 antibody or mouse IgG negative
control was added to 200 μg protein and gently rotated at 4 1C
overnight. The immunocomplex was captured by adding 25 μl
protein AþG agarose beads (Beyotime, Beijing, China) and gently
rotating at 4 1C for 3 h. Then the mixture was centrifuged at 2500g
for 5 min at 4 1C and the supernatant was discarded. The precipitate
was washed for three times with ice-cold RIPA buffer, resuspended in
3 sample buffer and boiled for 5 min to dissociate the immuno-
complex from the beads. The supernatant was collected by centrifu-
gation and subjected to SDS-PAGE as descriped followed by western
blotting with Cyp2a5 or Nrf2 antibody.
Western blot
Protein levels were determined by Western blotting. Solubilized
sample suspensions were boiled for 5 min, and proteins (20 μg of
liver microsomal proteins for detection of CYP2A5 proteins; 15 μg of
cytosolic or nuclear protein for detection of Nrf2 protein) were
loaded and separated using SDS-polyacrylamide gel electrophoresis
(12%), electrophoretically transferred to nitrocellulose/polyvinylidene
diﬂuoride membranes (Pierce Biotechnology, Rockford, IL/Bio-Rad
Laboratories, Hercules, CA), and blocked for 1 h in phosphate-
buffered saline containing Tween 20 (0.1%) and nonfat milk (5%).
Blots were incubated with CYP2A5 (1:1000 dilution), or Nrf2 (1:500
dilution) antibody for 3 h. Membranes were then incubated for 1 h
with horseradish peroxidase-conjugated goat anti-rabbit (1:5000
dilution) or goat anti-mouse (1:5000 dilution) antibody. After further
washing with phosphate-buffered saline, blots were incubated in
commercial chemoluminescence reagents (Amersham Biosciences).
Band intensities were measured using Quantity One software (Bio-
Rad, Hercules, CA).
Data analysis
Data was analyzed by the SAS 13.0 (The SAS Institute, Cary, NC).
Differences in all of the measured endpoints between the control
and the treatment groups were compared by ANOVA and GLM
Model of the SAS.
Results
Serological proﬁles
Experiments were performed to determine the effect of eight
weeks high-fat diet on hepatocellular integrity in Nrf2þ /þ mice
and in the Nrf2 / mice (Table 2). The mice (Nrf2þ /þ or Nrf2 /)
with high-fat diet had signiﬁcantly higher TC, LDL, GLU, ALT, AST
(Po0.01), and ALP levels (Po0.05) than did the mice in the
control group. However, the TP levels were signiﬁcantly lower in
the mice with high-fat diet than mice in the control (Po0.01).
Mice in the Nrf2 /control group exhibited signiﬁcantly different
levels of TC, HDL, TP, ALT and ALP (Po0.05 or Po0.01) than the
mice in the Nrf2þ /þ control group. Similarly, the mice in the
Nrf2 / high-fat model group exhibited signiﬁcantly different
levels of TG, TC, HDL, LDL, TP, ALT, AST and ALP (Po0.05 or
Po0.01) compared to the mice in the Nrf2þ /þ high-fat group.
Histological proﬁle
All of the sections in the experimental groups exhibited diffuse
hepatic steatosis (Fig. 1) under a light microscope, whereas no
fatty liver was observed in the control group. The relative sizes of
the hepatic cell nuclei were uneven. Hepatic steatosis (mostly
microvesicular and macrovesicular mixed steatosis) was most
Table 1
Primer sequences used in mRNA quantitation by reverse transciption-polymerase chain reaction.
Gene Forward primers Reverse primers
Cyp2a5 5′–GGACAAAGAGTTCCTGTCACTGCTTC-3′ 5′–GTGTTCCACTTTCTTGGTTATGAAGTCC-3′
Gclc 5′–TTTGAGAACTCTGCCTATGTGGT-3′ 5′–ATAAAACATCCCCTGCAAGACA-3′
r-GCS 5′–ATGCGGTGGTGCTACTGATTG-3′ 5′–CATCTCGGAAGTACACCACAG-3′
Catalase 5′–ACATGGTCTGGGACTTCTGG-3′ 5′–CAAGTTTTTGATGCCCTGGT-3′
Ngo1 5′–CGCCTCGAGGCCTCTGAATACTTTCAACAA-3′ 5′–GCGAAGCTTTCGGAGAGATCCTTAGGGCTG-3′
Gsta1 5′–CCCCTTTCCCTCTGCTGAAG-3′ 5′–TGCAGCTTCACTGAATCTTGAAAG-3′
Ho-1 5′–CACGCATATACCCGCTACCT-3′ 5′–CCAGAGTGTTCATTCGAGCA-3′
GAPDH 5′–GCACCACCAACTGCTTAGCCCCCCTG-3′ 5′–CACAAACATGGGGGCATCGGCAGAAG-3′
Table 2
Serum characteristics of WT and KO mice with or without NAFLD.
Parameters Controls(Nrf2þ /þ) NAFLD(Nrf2þ /þ) Controls(Nrf2 /) NAFLD(Nrf2 /)
TG (mmo/L) 0.9170.14 0.7870.15 1.0670.11 1.2370.23†
TC (mmo/L) 2.3970.39 11.3371.39nn 5.3070.42†† 7.8170.23nn†
HDL (mmo/L) 1.2970.20 1.4470.10 2.7570.51† 2.8170.18††
LDL (mmo/L) 0.2670.6 2.1270.28nn 0.270.04 0.8870.05nn††
TP (g/L) 1.9070.10 1.0170.19nn 1.5670.05†† 1.0470.07nn
GLU (mmo/L) 4.9070.40 8.5370.46nn 5.1670.15 8.5770.30nn
ALT (IU/L) 71.33710.21 135.67710.97nn 45.6778.08† 165.33714.98nn†
AST (IU/L) 238.33715.89 439744.16nn 223.67713.32 336.33713.65nn†
ALP (IU/L) 101.33710.02 192.33719.13n 20577.21†† 430.67722.03nn††
The data are expressed as the mean 7SD (n¼3 per treatment group). †Statistically different from wild type on the same diet; nstatistical difference caused by the high-fat
diet within each genotype. nPo0.05, nnPo0.01; †Po0.05, ††Po0.01. ALT, alanine aminotransferase; AST, aspartate aminotransferase; ALP, alkaline phosphatase; TG,
triglyerides; TC, total cholesterol; TP, total protein; HDL, high-density lipoprotein; LDL, low-density lipoprotein; NAFLD, nonalcoholic fatty liver disease.
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obvious around the portal area and was accompanied by liver cell
necrosis and inﬂammatory cell inﬁltration. The lobular and portal
areas exhibited considerably more inﬂammatory cell inﬁltration in
the experimental group than in the control group. The total
histological scores of the livers in the model-group mice reached
grade 2 or 3. Livers from WT-high-fat mice showed a minimal
degree of microvesicular steatosis. Most signiﬁcantly, livers from
Nrf2 KO-high-fat mice exhibited severe macrovesicular steatosis
and mild microvesicular steatosis, indicating that diffuse hepatic
steatosis with moderate inﬂammation (NAFLD) had developed.
Hepatic antioxidant capability and lipid peroxidation
The levels of oxidative liver damage were assessed by GSH,
SOD, POD and MDA levels (Fig. 2). In WT and KO mice fed with
high-fat diet, hepatic GSH and SOD levels were signiﬁcantly lower
(Po0.05) than the mice in control group, while, WT and KO mice
fed with high-fat diet had higher (Po0.05) POD and MDA
concentrations than mice fed with normal diet. Compared with
WT mice, KO mice MDA levels increased by 49% when fed with
high-fat diet (Po0.05). GSH, SOD and POD levels in WT and KO
mice were not signiﬁcantly changed when fed with high-fat diet,
while fed with normal diet, SOD, POD and MDA levels in KO mice
were signiﬁcantly higher (Po0.05 or Po0.01) than in WT mice,
but GSH was signiﬁcantly lower (Po0.01).
Effects of the high-fat diet on the mRNA expression of Nrf2 target
genes
Messenger RNA expression of several Nrf2 target genes is
shown in Fig. 3. The expression of γ-GCS, Nqo1, GSTA1and HO-1
mRNA was induced by the high-fat diet in Nrf2þ /þ and Nrf2 /
mice. However, no induction of CAT and GCLC was observed in
KO mice fed with the high-fat diet. Furthermore, in KO mice fed
with high-fat diet all of the Nrf2 target genes expression were
signiﬁcantly lower (Po0.05 or Po0.01) than the WT mice fed
with high-fat diet.
Effect of high-fat diet on cellular distribution of Nrf2
Cellular localization of Nrf2 protein was determined by Wes-
tern blotting. As shown in Fig. 4, a signiﬁcant decrease in Nrf2
protein levels in the cytoplasm was observed after treatment with
high-fat diet. However, Nrf2 protein levels in the nucleus were
higher in high-fat diet group mice livers than that in control mice
livers. These results suggested that the high-fat diet induced a
translocation of Nrf2 from the cytoplasm to the nucleus.
Effects of high-fat diet on Cyp2a5 expression in Nrf2þ /þ and Nrf2 /
mice
To evaluate the role of Nrf2 in high-fat diet induced CYP2A5,
levels and activities of CYP2A5 in livers from WT and KO mice
were assayed (Fig. 5). Expression of CYP2A5 was increased by 23%
in WT mice fed with high-fat diet, but CYP2A5 expression was
increased by 13% in KO mice fed with the high-fat diet compared
with the mice in the control group (Fig. 5B). CYP2A5 mRNA
induction by high-fat diet was comparable (73% vs. 20%) in WT
mice and Nrf2 / mice (Fig. 5C). CYP2A5 activity was increased by
35% in WT mice fed with the high-fat diet but 16% in KO mice
(Fig. 5D). Furthermore, induction of CYP2A5 by high-fat diet in
Nrf2 / Mice was lower compared to the WT mice. These results
suggested that Nrf2 plays a modulatory role in the high-fat diet
induction of CYP2A5.
The interaction between Nrf2 and Cyp2a5
As shown in Fig. 6, Cyp2a5 protein was detected in the protein
complex from the imunoprecipitation of cell lysates using an Nrf2
antibody (Fig. 6A), and Nrf2 protein also was detected in the
imunoprecipitations of Cyp2a5 (Fig. 6B). Furthermore, in the high-
fat diet group both Nrf2 and Cyp2a5 protein expression were
higher signiﬁcantly (Po0.05 or Po0.01) than in control group
mice. There was no co-immunoprecipitation of Nrf2 with Cyp2a5
in the absence of antibody.
Fig. 1. NAFLD models in WT and KO mice were established by feeding with high-fat diet for eight consecutive weeks. Fresh sections were stained with H&E to demonstrate
lipid accumulation. The sections were examined by light microscopy, and the liver images are displayed at 200 original magniﬁcation: (A) Nrf2þ /þ mice on control diet;
(B) Nrf2þ /þ mice on high-fat diet; (C) Nrf2 / mice on control diet; (D) Nrf2 / mice on high-fat diet. The Nrf2þ /þ and Nrf2 / high-fat model groups liver sections
exhibited severe hepatosteatosis consisting of mixed microvesicular and macrovesicular fat accumulation. The horizontal scale bar represents 100 μm.
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Fig. 2. NAFLD increased liver antioxidant and lipid peroxidation capacities in Nrf2 / mice. Glutathione (GSH) and Superoxide dismutase (SOD) concentrations were
quantiﬁed by colorimetric method to indicate the antioxidant capability of livers from mice expressing various amount of Nrf2. Peroxidase (POD) and Malondialdehyde
(MDA) levels were quantiﬁed as a measure of lipid peroxidation in mouse livers. The data are expressed as the mean 7SD (n¼3 per treatment group). †Statistically different
from wild type on the same diet; nstatistical difference caused by the high-fat diet within each genotype.nPo0.05, nnPo0.01; †Po0.05, ††Po0.01.
Fig. 3. NAFLD reduced mRNA expression of Nrf2 target genes in Nrf2 /mice. CAT, catalase; GClC, glutamate cysteine ligase catalytic; γ-GCS, γ-glutamylcysteine synthetase;
Nqo1, NAD(P)H:quinine oxidoreductase 1; GSTA1, glutathione S-transferase alpha 1 gene; HO-1, heme oxygense-1. The mRNA expressions of various genes were quantiﬁed
by RT-PCR, using mRNA GAPDH as an internal control. The data are expressed as the mean7SD (n¼3 per treatment group). †Statistically different from wild type on the
same diet; nstatistical difference caused by the high-fat diet within each genotype.nPo0.05, nnPo0.01; †Po0.05, ††Po0.01.
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Discussion
In this study we have shown the expected effects of high-fat
diet on hepatic steatosis, and induced hepatocyte necrosis and
inﬂammatory cell inﬁltration was more severe in the Nrf2 / mice
compared to the wild type Intact Nrf2/ARE signaling has been
demonstrated to effectively prevent hepatotoxicity in mice against
compounds such as acetaminophen [22], ethanol [23], and pyr-
azole [24] and this can now be extended to the high fat diets.
These data are consistent with previous studies which have shown
hepatic mitochondrial dysfunction, hypoxia and increased oxida-
tive and nitrative stress in response to high fat diets [25],
An important mechanism by which Nrf2 helps to maintain cellular
redox status is through regulating glutathione synthesis [26].
In the current study, the Nrf2 signaling pathway was activated by
the high-fat diet as indicated by increased nuclear accumulation of
Nrf2 proteins and the induction of Nrf2-target genes (Figs. 3 and 4).
Reduced glutathione (GSH) represents a major intracellular anti-
oxidant that protects against oxidative stress and the Nrf2 / mice
showed lower levels of GSH and several other ARE regulated genes
(Figs. 2 and 3) [27,28]. The impairment in antioxidant defenses was
associated with increased levels in the Nrf2 / mice under both
basal conditions and consumption of the high fat diet.
Interestingly, Cyp2a5 is upregulated in various pathophysiolo-
gical liver diseases and induced by structurally variable hepato-
toxic chemicals [20]. A putative common feature for all of these
conditions is altered cellular redox status. Nrf2 is a transcription
factor that is post-translationally regulated by oxidative stress and
controls transcription of numerous protective target genes. We
hypothesized that the magnitude of Cyp2a5 expression is tightly
Fig. 4. NAFLD induces a translocation of Nrf2 from cytoplasma to nuclear in WT mice liver. (A) Western blot analysis of cytosolic proteins fromwild-type control and high-fat
diet group mice livers, and quantitated protein band intensities presented as β-actin normalized mean values (n¼3)7SD. (B) Western blot analysis of nuclear proteins from
wild-type control and high-fat diet group mice livers, and quantitated protein band intensities presented as Histon H1 normalized mean values (n¼3) 7SDs. Mean
difference is signiﬁcant from control group at nn, Po0.01.
Fig. 5. CYP2A5 induction by NAFLD requires Nrf2. (A) Western blot analysis of microsomal proteins extracted from Nrf2þ /þ and Nrf2 / livers. (B) Protein blot densities
were quantiﬁed by Quantity One 1-D Analysis Software. Cyp2a5 protein was normalized to the loading control β-actin. (C) The mRNA expression of Cyp2a5 was quantiﬁed by
RT-PCR, using mRNA GAPDH as an internal control. (D) COH activities are in pmol of product formed/min per mg of microsomal protein. All values represent the mean7SD
(n¼3 per treatment group). †Statistically different from wild type on the same diet; nstatistical difference caused by the high-fat diet within each genotype.nPo0.05,
nnPo0.01; †Po0.05, ††Po0.01.
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connected with the hepatic protein level of Nrf2 in NAFLD model
mice, which could explain high CYP2A5 levels in pathophysiolo-
gical conditions involving oxidative stress. Our data suggested
that Nrf2 / mice suffer oxidative stress on the high-fat diet, as
evidenced by increases in hepatic POD and MDA. It seems
plausible that the inability of Nrf2 / mice to up-regulate their
antioxidant defenses when placed on an high-fat diet results in
lipid peroxidation and that this in turn leads to increased inﬂam-
matory cell inﬁltration and a strongly pronounced inﬂammatory
response. Presumably the increased lipid burden coupled with an
inability to maintain redox homeostasis facilitates the develop-
ment of NAFLD in the livers of mutant animals on the high-fat diet.
It has been reported that lipid peroxidation represents an impor-
tant event in the etiology of NAFLD [21], but further work is still
required to determine its precise contribution to the rapid onset of
NAFLD in Nrf2 / mice on the high-fat diet.
Xenobiotic metabolizing P450s may produce reactive metabo-
lites and sometimes ROS via enzymatic uncoupling. For example,
induction of CYP2E1 by ethanol is one of the central pathways by
which ethanol generates a state of oxidative stress in hepatocytes
[29]. Our current ﬁndings clearly show that Cyp2a5 is modulated
by Nrf2. Furthermore, our ﬁnding that Nrf2is bound to Cyp2a5 in
the liver might suggest some yet unidentiﬁed redox regulatory
function for CYP2A5. The putative role of CYP2A5 in antioxidant
defense is unclear at this moment. Interestingly, observations by
Abu-Bakar et al. [30], proposed a role for CYP2A5 in oxidative
metabolism of cellular bilirubin in conditions of excess production.
Thus, CYP2A5 could participate in controlling the cellular levels of
this potentially toxic compound with antioxidant properties.
Nrf2 regulates primarily an adaptive genetic survival program
that may, however, be harnessed by cancerous cells to promote
carcinogenesis and avoid apoptosis. In fact, increased Nrf2 activa-
tion and upregulation of several target genes has been detected in
various cancer cell lines and tumors [31]. This might explain why
elevated CYP2A5 expression is often detected in hepatocellular
carcinomas [9–12]. Detection of elevated expression of CYP2A5 in
liver tumors has resulted in the idea that this P450 enzyme,
capable of activating some hepatic carcinogens, could promote
carcinogenesis. However, regulation by Nrf2 suggests that upre-
gulation of CYP2A5 could also be a consequence than a cause of
tumor formation. Elevated expression of the orthologous human
isoform CYP2A6 has been associated with chronic inﬂammation,
and elevated CYP2A6 colocalizes with the inﬂamed areas in
human hepatocellular carcinomas [8,32,33]. A relevant question
is whether regulatory similarities between mouse CYP2A5 and
human CYP2A6 exist in relation to Nrf2-mediated signaling. Inter-
estingly, a positive correlation between hepatic CYP2A6 activity and
environmental cadmium exposure was found in an epidemiological
study on a healthy Thai population [34], supporting possible involve-
ment of Nrf2 also in regulation of CYP2A6. In conclusion, our current
results suggest that expression of CYP2A5 is modulated by Nrf2 in
response to a high fat diet.
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